Evolving Strategies for Leveraging SGLT2 Inhibitor Therapy in Type 2 Diabetes

Get patient-specific guidance on T2D treatment options and insights on managing CVD and CKD risk.

Share

Program Content

Activities

How I Use SGLT2 Inhibitors
How I Use SGLT2 Inhibitors in T2D for Cardiovascular and Renal Disease
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 10, 2020

Expires: November 09, 2021

Activities

SGLT2 Inhibitor Therapy
Slides on SGLT2 Inhibitor Therapy in Type 2 Diabetes
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2020

Expires: December 09, 2021

Activities

Diabetes Consult
Diabetes Consult: Selecting T2D Treatments for High-Risk Patients
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: April 12, 2023

No activities added yet

Provided by

ProCE Banner

Supporters

This activity is supported by an independent educational grant from

Boehringer Ingelheim